Call for network of Centres of Excellence in clinical research in Europe [10]

Lancet

Volumn 363, Issue 9412, 2004, Pages 901-902

  Clumeck, Nathan ^a   Katlama, Christine ^b  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTHORITY; CERTIFICATION; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG INDUSTRY; EUROPE; FINANCIAL MANAGEMENT; HUMAN; LETTER; MEDICAL EDUCATION; MEDICAL ETHICS; ORGANIZATION; PATIENT; POLITICS; PRIORITY JOURNAL; PUBLICATION; REGISTER; RESPONSIBILITY; SCIENCE; TECHNOLOGY;

EID: 1642351970     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15757-7     Document Type: Letter

References (5)

1. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official J Eur Commun 121: 33-44.
2. The Lancet. Who's afraid of the European Clinical Trials Directive? Lancet. 361:2003;2167.
3. Morice A.H. The death of academic clinical trials. Lancet. 361:2003;1568.
4. Meunier F., Lacombe D. European Organisation for Research and Treatment of Cancer's point of view. Lancet. 362:2003;663.
5. Flavell D.J., Sopsamorn U.F., Sullivan R. European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287. Lancet. 362:2003;1415.